Abstract
COPD is the third leading cause of death worldwide and a major cause of morbidity. Infection complicates COPD, both when patients are stable and during exacerbations. Exacerbations drive disease progression, lung function decline and premature death, therefore understanding and targeting airway infection are considered crucial. The interactions of bacteria, viruses and airway inflammation have all been shown to be a factor in stable COPD and in exacerbations. New molecular microbiology techniques are changing our view of COPD, identifying new bacterial species and a diverse microbiome which can be disturbed in chronic lung disease.
Bronchiectasis is increasingly recognized in COPD, and may be a distinct sub-type or “phenotype” of disease associated with greater bacterial colonization and inflammation. Increasingly, severe infections, and particularly pneumonia are recognized as common in COPD, and the role of inhaled corticosteroids in provoking bacterial colonization and development of pneumonia requires careful consideration. Long term antibiotic therapies are being explored as a means to prevent exacerbations and disease progression in COPD. This paper brings together the current knowledge related to the role of infection in COPD.
Keywords: Antibiotics, bacteria, COPD, exacerbations, infection.
Graphical Abstract
Current Respiratory Medicine Reviews
Title:The Role of Bacteria and Viruses in Chronic Obstructive Pulmonary Disease
Volume: 9 Issue: 6
Author(s): Kavita Valand and James D. Chalmers
Affiliation:
Keywords: Antibiotics, bacteria, COPD, exacerbations, infection.
Abstract: COPD is the third leading cause of death worldwide and a major cause of morbidity. Infection complicates COPD, both when patients are stable and during exacerbations. Exacerbations drive disease progression, lung function decline and premature death, therefore understanding and targeting airway infection are considered crucial. The interactions of bacteria, viruses and airway inflammation have all been shown to be a factor in stable COPD and in exacerbations. New molecular microbiology techniques are changing our view of COPD, identifying new bacterial species and a diverse microbiome which can be disturbed in chronic lung disease.
Bronchiectasis is increasingly recognized in COPD, and may be a distinct sub-type or “phenotype” of disease associated with greater bacterial colonization and inflammation. Increasingly, severe infections, and particularly pneumonia are recognized as common in COPD, and the role of inhaled corticosteroids in provoking bacterial colonization and development of pneumonia requires careful consideration. Long term antibiotic therapies are being explored as a means to prevent exacerbations and disease progression in COPD. This paper brings together the current knowledge related to the role of infection in COPD.
Export Options
About this article
Cite this article as:
Valand Kavita and D. Chalmers James, The Role of Bacteria and Viruses in Chronic Obstructive Pulmonary Disease, Current Respiratory Medicine Reviews 2013; 9 (6) . https://dx.doi.org/10.2174/1573398X10666140415200829
DOI https://dx.doi.org/10.2174/1573398X10666140415200829 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thiazolidinediones and Cardiovascular Risk — A Question of Balance
Current Cardiology Reviews Recently Patented and Widely Used Valves for Transcatheter Aortic Valve Implantation
Recent Patents on Cardiovascular Drug Discovery Editorial (Thematic Issue: From Gut Inflammation to Gastrointestinal Disorders Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities)
Current Pharmaceutical Design Cardiovascular Effects of Ghrelin and Growth Hormone Secretagogues
Cardiovascular & Hematological Disorders-Drug Targets Metabolic Targets of Cardiac HormonesTherapeutic Anti-Cancer Effects
Current Pharmaceutical Design Pathophysiology of Airway Colonization in Critically ill COPD Patient
Current Drug Targets Targeting CSCs in Tumor Microenvironment: The Potential Role of ROS-Associated miRNAs in Tumor Aggressiveness
Current Stem Cell Research & Therapy Selective Serotonin Re-Uptake Inhibitors and Hyponatremia in Acutely Medically-Ill Inpatients
Current Drug Safety The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results
Current Cardiology Reviews Molecular Mechanisms in Rheumatic Diseases: Rationale for Novel Drug Development – Introduction
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design Redox Control of Cardiovascular Homeostasis by Angiotensin II
Current Pharmaceutical Design A High Burden of Ischemic Stroke in Regions of Eastern/Central Europe is Largely Due to Modifiable Risk Factors
Current Neurovascular Research B7-H3-targeted Radioimmunotherapy of Human Cancer
Current Medicinal Chemistry Cardiac Stem Cell Characteristics in Physiological and Pathological Conditions
Current Pharmaceutical Design Future Treatment for COPD: Targeting Oxidative Stress and its Related Signal
Recent Patents on Inflammation & Allergy Drug Discovery Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents
Current Cancer Drug Targets Acute Actions of Natriuretic Peptides in Coronary Vasculature and Ischaemic Myocardium
Current Pharmaceutical Design Immunoregulatory Impact of Food Antioxidants
Current Pharmaceutical Design FoxO3a Governs Early Microglial Proliferation and Employs Mitochondrial Depolarization with Caspase 3, 8, and 9 Cleavage During Oxidant Induced Apoptosis
Current Neurovascular Research